In the murine 4T1 breast cancer cell line, cells expressing the CD44v8-10 alternative isoform including the variable portion of exon 8 to 10 were found to have a higher metastatic potential than those only expressing the standard form of CD44. This evidence concerns the gene CD44 and breast cancer.